Report for: DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial

Title	DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
Published in	PLOS ONE, April 2013
DOI	10.1371/journal.pone.0059340
Pubmed ID	23577062
Authors	Barney S. Graham, Mary E. Enama, Martha C. Nason, Ingelise J. Gordon, Sheila A. Peel, Julie E. Ledgerwood, Sarah A. Plummer, John R. Mascola, Robert T. Bailer, Mario Roederer, Richard A. Koup, Gary J. Nabel
Abstract	DNA vaccine immunogenicity has been limited by inefficient delivery. Needle-free delivery of DNA using a CO2-powered Biojector® device was compared to delivery by needle and syringe and evaluated for safety and immunogenicity.

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Iceland	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Ireland	1	1%
Unknown	81	99%

Readers by professional status	Count	As %
Researcher	17	21%
Student > Master	13	16%
Student > Bachelor	13	16%
Student > Ph. D. Student	8	10%
Student > Doctoral Student	7	9%
Other	8	10%
Unknown	16	20%

Readers by discipline	Count	As %
Medicine and Dentistry	14	17%
Biochemistry, Genetics and Molecular Biology	12	15%
Agricultural and Biological Sciences	11	13%
Immunology and Microbiology	10	12%
Pharmacology, Toxicology and Pharmaceutical Science	5	6%
Other	13	16%
Unknown	17	21%

PLOS